U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (CRX02)Cat. No. WA1612Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (CRX02)Cat. No. WA1612
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (COVA208)Cat. No. WA1611
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (CMI Cuba 5G4)Cat. No. WA1610
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (CAT-01-106)Cat. No. WA1609
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (BT2111)Cat. No. WA1608
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (BSI-001)Cat. No. WA1607
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (BDC-1001)Cat. No. WA1606
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (BB 1701)Cat. No. WA1605
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (BAY 2701439)Cat. No. WA1604
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (BAT8001)Cat. No. WA1603
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (BAT1006)Cat. No. WA1602
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (ALT-P7)Cat. No. WA1601